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                                    INTRODUCTION
    Coagulase-Negative  Staphylococci  (CoNS)  are  ubiquitous  microorganisms  that 
predominate  the normal  skin  flora.  Due to their  ubiquitous  nature  and relatively  low 
virulence,  CoNS have long  been considered to  be clinically  insignificant,  and hence 
when isolated from clinical specimens, the clinicians and the microbiologists discarded 
them as contaminants. 
                  However, it is noted that under appropriate conditions, CoNS can produce 
serious human diseases and the incidence of such infections has clearly increased in 
recent years1,  9.  Moreover they are seen as one among the most commonly isolated 
organisms  in  the  clinical  microbiological  laboratory  1,  3.  According  to  the  National 
Nosocomial Infections Surveillance System, CoNS are among the five most commonly 
reported pathogens in hospitals3.
                    The postulated reasons for the current prevalence and clinical importance of 
these organisms include their great numbers on the skin, their selection as a result of 
wide spread usage of broad-spectrum antibiotics in the hospital, their ability to adhere to 
and form biofilm on the surfaces of vascular catheters and other medical devices, and 
their meager nutritional requirements1.
                   The emergence of CoNS as important potential pathogens is   partly due to  
the increased usage of  transient  /  permanent medical  devices and partly due to the 
growing appreciation of this group of organisms as opportunistic pathogens 2.  Infection 
caused  by  CoNS  is  increasingly  common  in  patients  having  indwelling  catheters, 
orthopedic appliances, prosthetic devices and urinary catheters. 
                Blood stream infections in neonates with IV catheter and orthopedic wound 
infections with implant devices are usually associated with Staphylococcus epidermidis3, 
5,  27.  Staphylococcus lugdunensis  is  mainly  involved in  causation of  prosthetic  valve 
endocarditis27. Staphylococcus haemolyticus is the second most frequently encountered 
CoNS species in the clinical laboratory 27.21. Staphylococcus saprophyticus is the second 
most common cause of urinary tract infections in females of reproductive age group1, 3.
              The pathogenicity of this clinically significant CoNS strains is due to the 
production  of  extra  cellular  polysaccharide  known  as  slime which  permits  these 
microorganisms to adhere to implants and protects them from host immune system and 
antimicrobial therapy 4, 7.  It is well documented that biofilms are difficult to eradicate and 
are often resistant to systemic antibiotic therapy, thus requiring the removal of infected 
devices 5.
                                 
              CoNS are  becoming  the reservoirs  of  multiple  antimicrobial  resistant 
determinants. Because of the enormous increase in emergence   of multi drug resistant 
CoNS strains  over  the last  decades,  particularly     methicillin  resistant  strains2,  it  is 
necessary to predict their potential pathogenicity. This could be done by demonstrating 
biofilm  formation  in  vitro,  and  evaluating  the  antibiotic  susceptibility  of  each  clinical 
isolate early in the course of infection, both of which will assist in providing appropriate 
antibiotic therapy and preventing implant removal 6.
                  It is essential to detect minor differences between related organisms to  
recognize the continued presence of an infecting strain or the environmental distribution 
of an epidemic strain. Combination of various typing systems is most advantageous for 
strain identification  8, which will  help in establishing improved methods for prevention, 
diagnosis, and therapy.
                                         
                   Among the various typing systems like phage typing, serological typing, 
biotyping,  and  antibiogram,  the  biotyping  has  frequently  been  used  (alone  or  in 
combination with the antibiogram) as a means to distinguish specific strains of CoNS for 
clinical and epidemiological purpose1.
                  Identification of isolates up to species level increases the knowledge of the  
pathogenicity of the various species of CoNS6  and to determine whether any particular 
species  is  more  likely  to  cause  serious  human  infection9.  It  also  contributes  to  the 
predictive  value  of  an  isolate  being  clinically  significant1.  Species  identification  is 
important  to  establish  epidemiological  trends,  to  determine  the  specific  cause  of 
infection, and to confirm the treatment failure6.  Hence ,the study.
                                       
                                                 AIM:
             The aim of the present study is to assess the various microbiological aspects of 
Coagulase-Negative  Staphylococci  (CoNS)  and  its  clinical  significance  with  special 
emphasis on demonstration of virulence factors and methicilin resistance. 
OBJECTIVES:
1. To identify CoNS among bacterial isolates from various clinical specimens.
2. Speciation and biotyping of CoNS isolates.
3. To ascertain the significance of pathogenic CoNS in causation of  
    infections, by demonstrating the virulence factors.
4. To evaluate the biofilm production by different methods.
5. To evaluate antimicrobial susceptibility pattern - methicilin resistance
      and multidrug resistance among CoNS.
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                                      REVIEW OF LITERATURE
History
 About 150 years ago, cocci were first observed in diseased tissues and in 
pus obtained from human abscesses.
 In 1871, Von Recklinghausen named these organisms as “Micrococci” 
 In  1874,  Billroth  classified  these  organisms  on  the  basis  of  their  cell 
arrangements  into  Monococcos,  Diplococcos,  Streptococcos,  and 
Gliococcos.
 In  1882,  Ogston  named these pyogenic  organisms as  “Staphylococci” 
(Staphyle  -“a  bunch  of  grapes”  and  coccus  -  “a  grain  or  berry”),  an 
appropriate term derived from the Greek nouns11.
 In 1884, Rosenbach was the first to isolate staphylococci, grow it in pure 
culture, and study its laboratory characteristic10.  He named the orange 
and  white  colony  producers  as  Staphylococcus  pyogenes  aureus  and 
Staphylococcus pyogenes albus, respectively 10, 11.
 In 1891, the name Staphylococcus epidermidis albus was proposed for 
an attenuated form of Staphylococcus pyogenes albus10.   
 In 1905-1906, Andrewes and Gordon proposed a classification scheme 
for human staphylococci based on their pigmentation and pathogenicity in 
guinea pigs. Under this scheme, 4 species were recognized: S.pyogenes 
- orange, yellow, or white, highly pathogenic. S. epidermidis albus-white, 
16
feebly  pathogenic;  and  two  other  species  which  were  both  white  and 
nonpathogenic.
 In  Bergy’s  Manual  of  Determinative  Bacteriology,  from the first  edition 
(1923)  till  the  fifth  edition  (1939),  the  number  of  species  listed  under 
genus  Staphylococcus  varied  from  none  to  nine.  In  the  sixth  edition 
(1948), the Staphylococcus genus was deleted and all staphylococci were 
relegated to the genus Micrococcus. In the seventh edition (1957), the 
genus  Staphylococcus  was  reintroduced.  In  addition,  two  species,  S. 
aureus and S. epidermidis,  were recognized on the basis of anaerobic 
utilization of mannitol and the production of coagulase by the former. In 
the eighth edition (1974), the genera Staphylococcus, Micrococcus, and 
Planococcus  were  included  in  family  Micrococcaceae,  and  the  genus 
Aerococcus was placed in Streptococcaceae11.
 In  the 1986 edition  of  Bergy’s  Manual  of  Systematic  Bacteriology,  the 
family  Micrococcaceae  included  four  genera:  Planococcus, 
Somatococcus, Micrococcus, and Staphylococcus 21.
 In the road map of  the latest  edition of  Bergy’s  Manual  of  Systematic 
Bacteriology,the  genus  Staphylococci  is  placed  in  family 
Staphylococcaceae, genus planococci in family Planococcaceae, genus 
Micrococci  in  family  Micrococcaceae,  and the only  member of   genus 
stomatococci, Somatococcus mucilaginous, is placed in genus Rothia12, 21.
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                                              PATHOGENESIS
                  When isolated from clinical specimens, CoNS were hitherto considered 
as common contaminants.  However,  in  recent  years,  they are being increasingly 
recognized as pathogens12. Most of the CoNS are common inhabitants of the skin 
and mucous membranes. CoNS turn pathogenic when alterations in the integument 
due to wounds or implantation of foreign bodies allow these normal skin inhabitants 
to gain entry into the body, thus causing infections 9.
                   Over the last  several decades,  infection with CoNS has been  
characterized as related to “medical progress” (Rupp and Archer, 1994). The CoNS 
infections  originate  most  frequently  in  the  normal  skin  and  mucosal  flora  of  the 
patient contaminating the introduced implant during the course of surgery, or from 
the side of the surgical team, or environment or attending personnel. Apparently, the 
foreign  body  predisposes  the  patient  to  infection  with  what  would  otherwise  be 
innocuous bacteria36.
                                            
                   The organisms have been and continue to be pathogenic in patients with  
intravenous  catheters,  orthopedic  devices,  prosthetic  and  indwelling  foreign 
devices16,  causing  -  septicemia,  prosthetic  joint  infection,  prosthetic  valve 
endocarditis,  peritoneal  dialysis  catheter-associated  peritonitis,  cerebrospinal  fluid 
shunt  infections15,  and  permanent  urinary  catheter-associated  urinary  tract 
infections42.
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               The ability of CoNS to form biofilm, mainly on the surface of   foreign bodies 
in humans and also on the surface of tissues, plays the most important role in the 
pathogenesis of CoNS induced infections42. Tissue infections, the pathogenesis of 
which includes biofilm formation in the absence of foreign body, include urinary tract 
infection, skin abscesses, post operative wound infection, eye and ear infections9, 
and native valve endocarditis.  CoNS are common opportunistic  pathogens in the 
immune-compromised. (i.e. intensive care patients, premature newborns, cancer and 
transplant patients). In these patients, CoNS infections can often be  life-threatening1 
                 In recent days, CoNS are among the most frequently isolated bacteria in  
the clinical  microbiology  laboratory  3,  13.  Frequent  isolation  of    CoNS presents a 
recurring interpretive challenge to both clinical microbiologists and clinicians1. One of 
the major  problems  facing  the  clinical laboratory  is  in distinguishing clinically 
significant, pathogenic strains of  CoNS  from  any contaminant strains3,13. 
Epidemiology
                          As a result of the growing recognition that CoNS are clinically  
important, many studies have been initiated since 1958 to classify these organisms3.
•   In 1958, Smith and coworkers3,71 noted the potential pathogenicity of 
 CoNS by collecting data from patients with septicemia. 
• In 1962, Pereira72 reported that a certain group of CoNS (now known as S. 
saprophyticus) caused urinary tract infections (UTIs). 
• In 1965, Wilson and Stuart73 reported that CoNS were found in pure culture 
in 53 of 1,200 (4.4%) cases of wound infections. 
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• In  1971,  Pulverer  and  Pillich74 found  that  in  about  50% of  all  pyogenic 
lesions observed in hospital patients, CoNS were present in pure culture.
• In  the  1980s,  the  range  of  infections  believed  to  be  caused  by  CoNS, 
especially  by  S.  epidermidis,  was  quite  wide.  Though  S.  epidermidis 
accounts  for  most  CoNS  infections,  many  other  species  have  been 
identified in association with human infections.40,41.
• In  United  States,  during  the  late  1980s  and  early  1990s,  the  National 
Nosocomical Infections Surveillance System identified CoNS as one among 
the  five most commonly reported pathogens (in fifth place at 9 to 9.7%, 
compared  with  10  to  11.2%  for  Staphylococcus  aureus)  in  hospitals 
conducting hospital-wide surveillance 3,17.
              World-wide, CoNS are the most common cause of blood stream infections, 
the second most common cause of prosthetic valve endocarditis76, and second most 
cause of urinary tract infections (UTI) in females of reproductive age group21. 
              In United States, CoNS was the most frequently isolated bacteria from blood 
cultures18,  as  shown  in  studies77 by  Pfaller  (1999)  (32%),  Richards  et  al  (2000) 
(38%), Karlowsky et al (2002) (42%). 
              In United Kingdom, CoNS was found to be the most common cause of 
peritonitis  (29%)  by Kavanagh  et  al78.  CoNS was  also  the  commonest  cause  of 
bacteraemia in the Neonatal Intensive Care Units (NICU) in UK, accounting for two-
thirds of positive blood cultures79. 
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              In West Indies, Akpaka et al (2003) reported that CoNS was the most 
prevalent among blood culture isolates (284/854, 33%) 19                        
              In India, CoNS are now the most common organisms associated with late-
onset  septicemia,  accounting  for  more than 50% of  all  cases (Stoll  et  al.,  2002; 
Nataro et al., 1994; Freeman et al., 1987)80. According to Vinodkumar et al(208)., 
CoNS was the third most  common cause (13.4%) of  neonatal  septicemia20.  In  a 
study by Lakshmi et al (2006., CoNS was the most common isolate accounting for 
36.36% of central nervous system (CNS) shunt infection81. In a study by Mohanty et 
al., CoNS was found to be the second most cause (19.2%) of pyoderma.
Morphology21, 23
                       Staphylococci are gram-positive cocci of about 1µm in diameter. The 
cocci are arranged in grape-like clusters; however, when examined in pathological 
specimens or liquid culture, they may occur as 
single cells or pairs of cells. They are non-motile and non-sporing.  Capsule or slime 
layer  (diffuse  capsule)  may  be  present  more  commonly  in  vivo  -  especially  in 
colonization by Staphylococcus epidermidis.
               Cell  wall  contains  Ribitol  teichoic  acid  (Polysaccharide  A)  in  
Staphylococcus  aureus,  and  Glycerol  teichoic  acid  (Polysaccharide  B)  in 
Staphylococcus  epidermidis.  The  guanine  plus  cytosine  (G+C)  content  of 
Staphylococci DNA ranges from 30-40 mole% 26.
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Cultural characteristics21,27
               Staphylococci grow readily on media like blood agar, nutrient agar, tryptic  
soy agar, brain heart infusion agar ,etc. Growth occurs within a temperature range of 
10 - 420C, the optimum being 370C, and within           PH 7.4 - 7.6. They are aerobes 
or facultative anaerobes.
 In liquid media, uniform turbidity is produced.
 On MacConkey’s medium, small pink colonies are produced.
 On blood agar, hemolytic as well as non hemolytic colonies are produced.
 On nutrient agar, tryptic soy agar, and brain heart infusion agar, colonies 
are large, convex, smooth, shiny, opaque, and easily emulsifiable.
 The typical  CoNS colony is  non pigmented,  smooth,  entire,  glistening, 
convex, and opaque
 S. epidermidis colonies are small (1 to 2 mm in diameter depending on 
the strain), non-pigmented, and the slime-producing strains are sticky.
 S. haemolyticus colonies smooth, butryous, opaque, and may be non-
pigmented or cream to orange in color.
 S. hominis colonies mimic the characteristics of S.epidermidis colonies.
 S. lugdunensis colonies are larger, smooth, glossy, cream to orange in 
colour or non-pigmented, entire-edged, and their center is slightly domed. 
 S. warneri mimics the cultural characteristics of S. lugdunensis colonies27.
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 S.  schleiferi  colonies  are  non-pigmented,  smooth,  glossy,  and  slightly 
convex with entire edges.
 S. saprophyticus colonies are large, entire, very glossy, smooth, opaque, 
butryous, more convex, and half of the strains are pigmented.
 CoNS are strongly catalase-positive, and usually oxidase- negative22, 23. 
 S.  aureus  and  S.  intermedius  are  the  only  Coagulase-positive 
Staphylococcal species. All other staphylococci are Coagulase- negative 
(both free and bound Coagulase)
Species
                Forty species are currently recognized in the genus staphylococcus; about 
one-half of these are indigenous to humans 1, 2, 10, 23.
                    Although, at least 18 staphylococcal species have been isolated from 
human skin1, S. epidermidis accounts for more than half of the resident staphylococci 
with  extensive  distribution  over  the body surface.  In  terms of  clinical  isolates,  S. 
epidermidis is clearly predominant, comprising more than 75% of CoNS in clinical 
specimens29.  Other  clinically  significant  species  include  S.  saprophyticus,  which, 
after Escherichia coli, is the second most common cause of uncomplicated urinary 
tract  infections  in  women  younger  than  40  years;  it  is  particularly  prevalent  in 
sexually  active  women who are in  their  teens and twenties8.  S.haemolyticus,  the 
second  most  frequently  encountered  CoNS  species  associated  with  human 
infections  has been implicated in  native  wall  endocarditis,  septicemia,  peritonitis, 
wound, bone, and joint infections3. S.lugdunensiss has increasingly been recognized 
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as  a  cause  of  invasive  infections  that  include  endocarditis,  osteomyelitis,  and 
sepsis9. Other CoNS species like S. warneri, S. simulans, S. hominis,            S. 
capitis, and S. schleiferi are also implicated in various infections.
 According to Gill et al (1983), except for S. saprophyticus and            S. simulans,  
which were found more frequently in urine, the most common source for all other 
species combined was blood (50%), followed by wounds and abscesses (17%), and 
I.V. catheter tips (11%)31. 
                 In a study by Mohan & Jindal (2002), among 192 CoNS isolates,  urine 
was the source of 93 isolates (48.4%), followed by pus with 34 isolates (18%), drain 
tips / catheter tips / I.V. cannulas with 22 isolates (11.4%), blood with 9 isolates (5%), 
and aural swabs with 19 isolates (2.7%)35.
                In a study by Goyal et al 2 ( 2006), of the 102 CoNS strains, wound was the 
most common source (38.2%),  followed by urine samples (28.4%), blood cultures 
(14.7%),  catheters (10.7%),  cerebrospinal  fluid  (3.9%),  synovial  fluid  (1.9%),  and 
ascitic fluid (1.9%)..
             Among potentially  significant  CoNS that  were isolated  from clinical  
specimens, 75% were S. epidermidis, while S. haemolyticus and S. hominis were the 
second and third most frequently encountered species, respectively. The above were 
also the three most  common species isolated from blood cultures by Eng et  al15 
(1982), and from wounds and body fluids by Sewell et al 9 (1982)
             In a study by Goyal et al 2  (2006), among the clinically significant CoNS 
isolates,  41% were  identified  as  S.  epidermidis,  followed  by                 S.  
saprophyticus  (16.6%),  S.  haemolyticus  (14.7%),  S.  hominis  (14.7%),        S. 
lugdunensis (4.9%), S. schleiferi (1.9%), and S. capitis (1.9%). Only 4 isolates were 
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not identified to the species level;  two of which were probably   S. capitis subsp. 
ureolyticus / S. warneri / S. simulans.
              Recently, when Lorio et al. (2007) 14  evaluated 198 CoNS isolates from 
different clinical sites, 69 (34.8%) were S. epidermidis,  44 (22%) were          S. 
haemolyticus, and 25 (12.6%) were S.hominis isolates. The other         species 
identified included S.saprophyticus subsp. Saprophyticus (4%),              S.warneri  
(3.5%), S. lugdunensis (3%), S. capitis subsp. capitis (3%),                 S.cohnii subsp. 
urealyticum (2%), S. sciuri subsp.sciuri (2%), S. xylosus (2%),   S. capitis subsp. 
urealyticum (1.5%), and a single S. cohnii subsp. cohnii strain.
                 In a study by John et al34, the most common species among        the 
urinary  isolates  of  CoNS  was  S.  epidermidis  (53%),  followed  by 
S.hominis  (12%),  S.haemolyticus  (10%),  and  S.saprophyticus  (5%).  However, 
Nord  et  al67 reported  that  S.  saprophyticus  (44%),  S.  epidermidis  (23%),  and 
S. haemolyticus (14%) were the predominating species34.
VIRULENCE FACTORS
                   Slime production has been shown to play a major role in  the  
pathogenesis  of  infections  caused  by  CoNS.  According  to  Koneman  et  al21 and 
Cunha et al4, CoNS also produce other virulence factors such as hemolysin, lipase, 
protease,  urease,  and  DNAse.  Based  on  the  above  considerations, pathogenic 
CoNS are evaluated by demonstrating the virulence factors4, 21.
Virulence factors of Staphylococcus epidermidis 42
1. Factors  SSP-1, SSP-2, AtE and Delta toxin - Play a role in attachment to
     abiotic surfaces like polystyrene.
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2. Factors Fbe /SdrG, Embp, GehD - Aid in attachment to host matrix proteins by 
fibronectin- , fibrinogen-, and collagen-binding.
3. Factors PSA, PIA - Aid in cell-cell adhesion for accumulation.
4. Exoenzymes like,  
a. lipase for persistence in fatty acid secretion
b. Cystein protease to induce tissue damage
c. Metallo protease and Serine protease for biofilm formation and 
d. FAME which detoxifies bactericidal toxin in host
Regulators of Virulence:
agr - Affects lipase and protease production
sar – Affects virulence factors production
sig B – Affects biofilm formation
Virulence factors of staphylococcus saprophyticus 43
                         Autolysin Ass, mediates adhesion to fibronectin on uroepithelial  
surfaces  and  haemagglutination.  The  surface  fibrillary  protein  Ssp,  functions  as 
intercellular  adhesin  in  formation of  multilayered  clusters.  Other  virulence factors 
include urease ( which causes destruction of bladder), lipase, elastase, and FAME2 1, 
42.
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Virulence factors of staphylococcus lugdunensis 
 The infections caused by S. lugdunensis are more serious. They create bonds with 
host  molecules  by  producing  lipase,  elastase,  and  FAME.  S.  lugdunensis  is  not 
bound  to  fibrinogen  like  other  CoNS;  instead,  it  produces  peptides  called  S. 
lugdunensis Synergistic hemolysins (Slush) 42. 
Virulence factors of staphylococcus haemolyticus
 S. haemolyticus also produces peptides and bind to the host molecules.  They also 
produce Gonococcal growth inhibitor  factor(GGI).  The reduced susceptibility of S. 
haemolyticus to teicoplanin is due to substitution of glycine with other amino acids in 
peptidoglycon.
The above mentioned virulence factors are also produced by other CoNS species42. 
FAME is produced by S. capitis, S. hominis,               S. simulans, and S. cohnii.  
Urease is produced by S. capitis, S. hominis, and S. warneri. Lipase is produced by 
S. capitis, S. hominis, S. warneri, and           S. schleiferi.
Biofilms
                   CoNS, especially S. epidermidis, frequently infect biomedical implants, 
transcutaneous  devices  such  as  intravascular  and  peritoneal  catheter16,21, 
CSFshunts1,  and  prosthetic  cardiac  valves1,21.  The  pathogenesis  of  biomedical 
implant  infections  caused  by  S.  epidermidis  can  be  separated  into  two  distinct 
phases: 
(i) Primary bacterial adherence to the surface of the device and 
(ii) the production of a stable biofilm matrix over the surface of the device37. 
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I. The  primary  bacterial  adhesion  involves  rapid  adhesion  of  bacteria  to  a 
specific surface followed by their accumulation and proliferation. This results 
in the creation of multilayer clusters on the surface, whether, of the tissue or of 
the foreign body,  surrounded with extra cellular  material37.This initial  phase 
involves  Van  der  Waals  forces,  hydrophobic  interactions,  and  polarity 
changes. Whether the  surface of  the material is coated (“conditioning film”) 
or uncoated with host molecules is also of importance in adhesion . In  case of 
unmodified surfaces,  this interaction is mediated by the surface structures, 
SSP-1, SSP-2, AtE, and teichoic acid, of the bacteria 43. In case of modified or 
conditioned  surfaces,  adhesion  proceeds  with  the  assistance  of  proteins 
designated  as  MSCRAMMs  (Microbial  Surface  Components  Recognizing 
Adhesive Matrix Molecules) 4 . 
II. Proliferation or production of biofilm matrix, where-in bacteria accumulate to 
form multilayered cellular  clusters,  requires intra cellular  adhesion which is 
provided  by  the polysaccharide  intra  cellular  adhesin  (PIA),  and  the extra 
cellular protein along with accumulation associated protein (AAP).The genes 
responsible for the PIA formation are located on the ica operon which consists 
of icaR (regulating gene) and ica ABCD (biosynthetic gene) 26, 42.
It is now well documented that biofilms are notoriously difficult to eradicate and are 
often resistant to systemic antibiotic therapy and removal of infected device becomes 
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necessary9–11. The differentiation of CoNS with respect to its biofilm phenotype might 
help to elucidate the impact of CoNS in diagnosis of infections related to biomedical 
devices  and  these  observations  may  also  enable  prevention  of  device-related 
infections12.
            In a study by Christensen et al  (1982)51,   60% of clinically significant 
bloodstream isolates of CoNS produced slime.
            In a study by Ishak et al (1985) 52, 92.8% of clinically significant bloodstream 
isolates of CoNS, as well as 23% of contaminants, produced slime. Among the slime 
producers, S. epidermidis was the most prevalent constituting 92 % of the isolates. 
            Deighton et al (1988)47 found 48% of CoNS isolates from clinical specimens 
to be slime producers; of this,  53%  slime positivity was among   S. epidermidis 
species and 52% among S. haemolyticus.
          Kotilainen et al (1990)49 reported 65% slime production by pathogenic strains 
and 40% slime production by nonpathogenic strains of CoNS.
          Baldassarri et al (1993)54 noted that the fixation of bacterial films that were 
produced by a standard slime producing strain of  CoNS on plastic  tissue culture 
plates varied with  the type  of  fixative.  Bouin  reagent  is  reliable  but  is  potentially 
explosive, thereby marking it dangerous for routine use.
           Rathinam et al (1993)  55 reported that 40% out of 407 CoNS isolates tested 
positive for slime production. The prevalence rate of slime production among CoNS 
species were 62% for S. epidermidis, 38.6% for                       S. saprophyticus, 36%  
for S. hominis, 25% for S. cohni, and 17% for              S. capitis.
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               Phatak et al (1994) 56 showed that,  among the 106 CoNS isolates, 1 out of 
24 strains (4.17%) of  S.  saprophyticus  and 34 out  of  82 strains (41.46%)  of  S. 
epidermidis tested positive for slime productio         
   Makhija et al (1995)57 reported that 43 out of the 101 CoNS isolates from 
clinical specimens were slime producers. The percentage of slime-producing CoNS 
ranged from 20% in peritoneal fluid to 66% in CSF.          
  Mohan et al  (2002)35 reported slime producing CoNS from various clinical 
specimens.  Out  of  192  strains  of  CoNS,  slime  production  was  exhibited  by  77 
(48.7%) strains of S. epidermidis and 8 (26.6%) strains of      S. saprophyticus.
           A number of tests are available to detect slime production by Staphylococci. 
The methods include Micro  titer  plate (MTP) method5, 36,  Tube method (TM) 5,  38, 
Congo  red  agar  (CRA) 39, bioluminescent  assay41,  and  light  or  fluorescence 
microscopic  examination19,  20.  However,  these  methods  often  suffer  from  severe 
analytical limitations. 
            The adherence of CoNS to smooth surfaces was assayed by measuring the 
optical  densities  of  stained bacterial  films adherent  to  the  floors of  plastic  tissue 
culture / micro titre plates. The optical densities of bacterial films adherent to plastic 
tissue culture  / micro titre  plates serve as a quantitative model for the study of the 
adherence of CoNS to medical devices, a process which may be important in the 
pathogenesis of foreign body infections36. The measurements also agreed with visual 
assessments of bacterial adherence to culture tubes.
                  In  a study by Mathur  et  al5,  the modified  tissue culture plate 
method(TCP)was most sensitive (96.2%), specific (94.5%), and accurate (97.3%) in 
terms of discriminating between biofilm producers and non-producers. In the case of 
30
tube method(TM), though the strong biofilm producers could be easily detected, the 
difficulty  in  differentiating  between  moderate  and  weak  biofilm  forming  isolates 
affected  its  performance  in  terms  of  sensitivity  (77.9%),  specificity  (96.0%),  and 
accuracy (86.8 %). The (CRA) congo read agar method showed very little correlation 
with corresponding methods, and the parameters of sensitivity (7.6 %), specificity 
(97.2 %), and accuracy (51.3 %) were very low. The Tissue culture plate  or MTP 
method also has the advantage of being a quantitative model to study the adherence 
of  staphylococci  on  biomedical  devices,  a  finding  reported  by  Christensen  et  al 
(1983)8 
Speciation
                      In the hospital microbiology laboratory, identification of Staphylococci is 
often limited to a rapid screening test for S. aureus, while non-S. aureus isolates are 
simply reported as CoNS 6. The clinical significance of CoNS continues to increase 
as strategies in medical practice lead to more invasive procedures. It is crucial to 
reliably identify these organisms in order to shed light on the clinical significance of 
infections caused by each Staphylococcal species, and to provide data for control 
and epidemiological measures.
Identification and speciation of CoNS by the reference method of Kloos and Schleifer 
involves 36 tests3;  it  is  a reliable but  relatively cumbersome and time consuming 
method that requires expensive reagents which are not routinely available in most of 
the clinical laboratories. Several commercial kit identification systems and automated 
instruments, which can identify a number of Staphylococcus species accurately, are 
currently available. However, they are still out of reach of most of the laboratories in 
developing countries2, 14. Hence, convenient, reliable, and inexpensive identification 
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methods are needed to identify most of the CoNS, which are commonly implicated in 
majority of infections. 
            Simplified method using nine tests for CoNS identification, evaluated by Iorio 
et al (2007)14, identified 12 clinical species of CoNS, including            8 subspecies, 
with an accuracy of 98.5%.
             Another simple scheme employing minimal number of tests was adapted by 
Goyal et al (2006)2 for the rapid identification of CoNS. In this two-step procedure-
based  scheme,  the  first  step  involves  identification  of  species  group,  and,  if 
identification requires additional  tests,  a maximum of  two tests were selected for 
second step. The shortcoming of this scheme is the exclusion of the important PYR 
test which differentiates warneri species. 
                     A rapid 4-hour method (UZA method) has been developed by Leven et 
al  at  the  Laboratory  of  Microbiology,  University  Hospital,  Antwerpen, 
Belgium(1995)30.  This  method,  which  detects  the  enzymatic  activity  of  heavy 
bacterial  suspensions  in  three  substrate  solutions  (non  growth  tests),  correctly 
identified 97.7% of CoNS isolates within 4 hours.
                   The five-test simple scheme designed by De Paulis et al (2003)6, focuses 
on the species or species groups encountered among clinical isolates .  The species 
groups  were  defined  according  to  their  biochemical  reactions  rather  than  their 
phylogenetic relationships.  The addition of one or two tests within each particular 
species group could complete the strain identification,  even the most infrequently 
isolated species. Of the 201 strains, 200 (99.5%) were identified by the reference 
method, and the results were similar to those from the simple scheme identification 
method.
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TYPING METHOD
                   Several different epidemiological typing methods have been applied to 
study  CoNS.  Epidemiological  typing  scheme  for  CoNS  is  required  for  strain 
identification,  which  has  become  important  since  the  recognition  of  the  clinical 
significance of CoNS. The typing methods include biotyping (biochemical profiles), 
serological typing, phage typing (bacteriophage susceptibility patterns), DNA typing 
(plasmid profiling, restriction endonuclease  analysis of plasmid and  chromosomal 
DNA hybridization), and antibiogram (antimicrobial susceptibility profiles).
           More recently, research groups have been working on a typing scheme that  
uses a combination of several techniques. Hebert et al47 used a combination of the 
API Staph-Ident biochemical profile along with adherence and synergistic hemolysis 
to define biotypes of CoNS. This scheme, with the addition of five antibiotic discs 
(Novobiocin, Polymeric B, Bacitracin, Furazolidone, and TaxoA) and pyroglutamyl-3-
naphthylamide hydrolysis,  allowed separation of  strains within  the S.  lugdunensis 
and S. schleiferi species into several biotypes. 
          Herwaldt et al48 incorporated the API Staph Trac, antibiotic profile, slime 
production, and synergistic hemolysis for successful strain discrimination.
          Ludlam et al49 achieved 95% of the discriminatory power of the scheme when 
they used plasmid analysis along with antibiograms or biotyping and phage typing 
along with antibiograms.
             With the ease in obtaining an antibiogram and a biotype, these techniques in 
combination  would  provide  a  moderate  degree  of  strain  delineation  for  those 
laboratories that are not able to incorporate more advanced techniques. The timely 
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delineation of specific phenotypic              (or genotypic) profiles of CoNS by one or  
more of the above methods will  provide the basis for studies that are designed to 
answer important epidemiologic and pathogenic questions.
Biotyping
 The generation of a biochemical profile or biotype has frequently been used, (alone 
or  in  combination  with  the  antibiogram)  as  a  means  of  distinguishing  strains  of 
CoNS8.  Several different biotyping systems were proposed for both taxonomic and 
epidemiologic  purposes.  These  systems,  based  on  numerous  biochemical  and 
physiological tests, included those proposed by Baird-Parker11, Bentley et al44, Holt45, 
and several others.
                    Of the various biotyping schemes, only those of Baird-Parker and 
Bentley have received much attention. The Baird-Parker system deals primarily with 
strains  from  non  clinical  sources,  and,  in  general,  places  more  emphasis  on 
taxonomy8,50.  The Bentley et  al.  system,  which includes six  stable  tests  (Maltose, 
Mannose,  Lipase,  Phosphatase,  Glucuronidase,  Gelatinase)  was  developed 
specifically  for  epidemiological  purpose  and  it  has  often  been  used  in  clinical 
situations44. 
                      The role of S. epidermidis in severe infections involving the  
colonization of prosthetic devices is well  established. Because of its resistance to 
treatment, infections by S. epidermidis can present therapeutic problems21. To date, 
the most generally accepted method to distinguish subgroups of S. epidermidis is the 
biotyping scheme of Baird-Parker. The purpose of this study was to apply this typing 
scheme to S. epidermidis isolated from patients, and to correlate biotype with clinical 
source and the production of virulence factors.
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Serological typing
                Serological typing has been useful as an epidemiological tool in the 
investigation  of  a  variety  of  infectious  diseases;  however,  it  has  not  been  well 
developed for  use with  CoNS1.  As  might  be expected,  this  is  largely  due to the 
difficulties  in  preparing  specific  antisera  and  in  the  standardization  of  typing 
methods10. Given the availability of other typing systems for CoNS, serotyping does 
not appear to have much of a role in epidemiological studies of these organisms.
Phage typing
        The most established system for epidemiological typing of Staphylococci is the 
determination  of  bacteriophage  susceptibility  patterns  (phage  typing).  Currently, 
there 4 are major  phage-typing sets available  for  CoNS1,  including those of  Van 
Bovenet al., Pulverer et al. ,Dean et al., and Parisi et al 10  .
               According to an international collaborative study, none of the phage typing  
systems  was  satisfactory  with  regard  to  typability,  reproducibility,  and 
discrimination10. Despite these problems, phage typing has been used successfully 
to type CoNS, particularly in epidemic situations. 
               Christensen et al. (1983) 8 demonstrated that phage typing by itself was a 
poor strain discriminator in a non epidemic situation; however, when combined with 
antibiogram and biotyping, phage typing provided adequate discrimination between 
strains. The authors suggested that the phage typing of CoNS is better reserved for 
epidemic, rather than endemic, situations1.
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Molecular typing
           The application  of  molecular  typing  through plasmid pattern analysis, 
restriction endonuclease (RE) analysis of plasmid and chromosomal DNA, and DNA 
hybridization,  is proving to be a promising mean of identifying strains or a clonal 
population of Staphylococci.
           Plasmid analysis has been shown to be useful in a number of clinical  
situations  and  in  differentiating  contaminants  from  pathogens  which  cause 
septicemias, prosthetic valve endocarditis, intravenous catheter sepsis, urinary tract 
infections,  and  osteomyelitis1.  Further  identification  of  individual  plasmids  can  be 
achieved  by  RE  treatment  of  the  plasmids  followed  by  gel  electrophoresis.The 
techniques of RE analysis and DNA hybridization provide additional information on 
the nucleotide sequence within the plasmid, thus enabling the confirmation of the 
identity  between plasmids  with  a high degree ofconfidence66.  Genotypic  markers, 
which are more useful for the assessment of strain identity, can at present be carried 
out by only a few laboratories66.
Antibiogram
              Antibiogram, being the easiest and most frequently used test, has been 
suggested  as  the  primary  tool  for  the  typing  of  CoNS  3.  Because  of  the  ready 
availability and pattern variety,  clinicians frequently apply antibiograms toward the 
identification of clinically significant strains of CoNS8. The presence of a strain with a 
unique  antibiotic  susceptibility  pattern  can  provide  a  marker  for  detecting  similar 
isolates;  however,  CoNS  are  pathogens  associated  with  multiple  antimicrobial 
resistance mechanisms including, in particular, methicillin resistance 59.
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             CoNS have historically been more resistant to antimicrobials, including the 
β-lactam antibiotics, than S. aureus; some hospitals report that the rates of oxacillin 
resistance in  CoNS is  approaching  90%61.   Eighty to 90% of  CoNS produce an 
inducible  beta-lactamase.  The most  important  mechanism for  resistance to beta-
lactam is the production of a low-affinity penicillin-binding protein, PBP2a70, which is 
encoded by the mecA gene. Various CoNS species harbor the mecA determinant 
which  confers  resistance  to  the  penicillinase-resistant  penicillins,  such  as 
dicloxacillin, methicillin, nafcillin, and oxacillin63. The presence of the mecA gene in a 
Staphylococcal  isolate  is  considered  to  be synonymous  with  oxacillin  resistance. 
Thus, genetic assays for mecA have often been used as the reference method for 
evaluating new methods of antimicrobial susceptibility testing for staphylococci68,69  .  
                 Most of these methicillin-resistant CoNS were also resistant to multiple 
additional  antimicrobial  agents. Multi-resistant  CoNS also  commonly  colonize  the 
skin of hospitalized patients and hospital personnel.  Widespread skin colonization 
serves as a potential reservoir for multi-resistant isolates that can cause infections, 
particularly infections of indwelling intravascular devices. In addition, these colonizing 
isolates serve as a reservoir for antibiotic resistance genes that can transfer among 
CoNS and be acquired by S. aureus70.
                  Staphylococcal biofilm formation is quite common in CoNS infections and 
it reduces the organism’s susceptibility to specific antimicrobials. The mechanism of 
biofilm-associated antimicrobial resistance is likely to be multifactorial. The problem 
of antibiotic-biofilm interaction has recently become a stimulus to develop antibiotics 
that  can  offer  some  promise  of  penetration  of  biofilm  to  inhibit  or  kill  adherent 
staphylococci62.
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                  In a study by John, Gramling, and O’Dell (1978)60, 24% of the CoNS 
isolates were sensitive to all the antibiotics tested. The incidence of resistance was 
greater  for  penicillin  (35%),  followed  by  tetracycline  (33%),  methicillin  (27%), 
sulfonamide (24%), erythromycin (15%), and clindamycin (13%); only five isolates 
(4%) were resistant to cephalothin.
              Gill et al (1983)31 reported that the resistance to oxacillin was highest among 
isolates of S. haemolyticus (76%), followed by S. epidermidis (38%). Sixty four to 
76%  of  isolates  of  S.  haemolyticus  showed  resistance  to  oxacillin,  cephalothin, 
cefoxitin,  erythromycin,  clindamycin,  gentamicin,  and  tobramycin;  S.  epidermidis 
showed only 33-51% resistance.
                 Mary et al (1996)63, based on PCR-based detection of mecA, reported 
49% of methicillin resistance among CoNS isolates.
                 In a study by Goyal et al (2006)2, the antibiotic susceptibility pattern  of 
CoNS isolates revealed no resistance to vancomycin; however, 89% were resistant 
to ampicillin,  59% to cefotaxime, 25% to cloxacillin, 23% to erythromycin, 29% to 
ciprofloxacin,  and 20% were resistant to gentamicin .
               In a study by Singh et al (2006)64, CoNS exhibited maximum resistance 
against  penicillin  (80%)  and  ampicillin  (80%),  followed  by  erythromycin  (54%), 
ciprofloxacin (54%), oxacillin (38%), rifampicin (32%), chloramphenicol (32%), and 
gentamicin (28%); no resistance to vancomycin was seen.
               Chaudury et al (2007)65 reported 68.4% of oxacillin-resistant CoNS, and all 
the strains were sensitive to vancomycin and linezolid. 
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              When the strains are susceptible to oxacillin, β-lactam drugs are preferred 
over vancomycin because, β-lactam drugs are easily absorbed into body fluids and 
tissues, cause fewer complications from treatment, and prevent unnecessary use of 
vancomycin.
             Many studies demonstrate the high prevalence of oxacillin resistance among 
hospital isolates of CoNS in India7. Thus, there has been a pressing need for newer 
antimicrobial agents with good anti-staphylococcal activity. Vancomycin, along with 
newer agents like Linezolid and Clindamycin, remains the drug of choice for treating 
MDR CoNS61.
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 METRIALSAND METHODS
Study design
The  present  study  was  conducted  on  CoNS  isolates  obtained  from  specimens 
submitted by in-patients and out-patients at the Diagnostic microbiology laboratory, 
Dept of Microbiology, Coimbatore Medical College, Coimbatore, during the period of 
June, 2007 to July, 2008                                    
A total of 135 CoNS Strains were isolated from deep wounds, blood samples, pus, 
urine samples, body fluids, and IV catheter tips by conventional cultural methods. Of 
the 135 isolates, 90 were considered as clinically significant. The following criteria 
were considered while determining the clinical significance of a CoNS isolate9.
Inclusion Criteria
1. Strains isolated in pure culture from specimens 
2. The culture was from body fluids (blood, cerebrospinal fluid, urine, pleural fluid, 
joint fluid, peritoneal fluid, etc.), or from a purulent, draining wound
3. High colony-count urine samples (>105 organisms per ml)
4. I.V. catheter tips > 15 colonies,
5.  Significant  clinical  symptoms  of  diseases  like  fever,  purulent  discharge  from 
wound, signs of general & local Inflammation, and repeated urinary tract infections.
6. Laboratory criteria like increased count of WBC, ESR, CRP, etc.
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Exclusion criteria            
1.  Organism isolated as mixed growth
2.  Growth only in broth 
3.  Growth after 72 hrs.
4.  No significant clinical symptoms of disease in patients                   
The procedures used in this study were approved by the Ethics Committee of the 
College. The strains collected were initially identified by colony morphology, Gram 
staining,catalase,  slide  and  tube  coagulase  (read  after  4  &  24  hours).  Acid 
production from glucose in Hugh and Leifson’s OF base, and bacitracin (0.04 U) 
susceptibility were determined to exclude Micrococcus spp.
1. Colony Morphology following culture
Strains were cultured on Nutrient agar plate and Blood agar plate. After 24hrs of 
incubation at 370C, Nutrient agar plates were examined for colony morphology and 
pigment production, while Blood agar plates were examined for colony morphology 
and haemolysis.
1. O/F Glucose test (Modified Hugh & Leifson) 82, 84
 Principle 
 The test is performed to determine the ability of the bacteria to utilize a carbohydrate 
(Glucose)  by  oxidative  or  fermentative  metabolism,  thereby  enabling  the 
differentiation between Staphylococci and Micrococci. Staphylococci produce acid by 
fermentation  both  in  the  anaerobic  tube  sealed  with  paraffin  and  in  the  aerobic 
unsealed tube. 
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Staph OF medium 
Tryptone 10.0 grams, Yeast extracts 1.0 gram, Agar 2.0 grams, Bromothymol blue 
0.04 gram, and Glucose 10.0 grams, in 1000 ml water.
Method
The  test  culture  was  inoculated  into  two  test  tubes  containing  the  medium  by 
stabbing down their whole length with a long straight wire. One of the stab-cultured 
tube was covered with vaspar (1:1 Petrolium jelly and paraffin) or a layer of sterile 
liquid paraffin, and both tubes were incubated at 370C for      48 hours .
Interpretation
The cultures which produced acid by fermentation in both tubes were considered as 
Staphylococci,  and  the  cultures  which  produced  acid  only  in  aerobic  tube  by 
oxidation were discarded as Micrococci.             
2. Bacitracin sensitivity 82, 83
This test is performed to differentiate between Staphylococci from Micrococci.
Procedure
 A suspension of test isolate with a 0.5 McFarland standard turbidity was prepared. 
The test culture was swabbed on the Muller Hinton Agar and plates. Using heated 
forceps, a bacitracin disc impregnated with 0.05 µg of bacitracin was placed over the 
surface of the inoculated media and incubated for 24 hours.  
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Interpretation
 Organisms  showing  less  than  10  mm  of  inhibitory  zone  were  considered  as 
Staphylococci,  and organisms showing more than 10 mm of inhibitory zone were 
discarded as Micrococci
3. Coagulase test
Principle
The test is performed to determine the ability of an organism to clot plasma by the 
action of the enzyme coagulase, and is used to differentiate between      S. aureus 
and CoNS.
a. Slide Coagulase test 82, 85 (Williams and Harper 1946)
 This test detects bound coagulase.
1. A single colony was emulsified in a drop of saline on a clean glass slide with a 
minimum of spreading. If the isolate did not form a smooth milky suspension, the test 
was aborted at that step. 
2. Similar suspensions were made for positive and negative control strains to confirm 
the proper  reactivity  of the plasma.
3. A straight inoculating wire, flamed and subsequently cooled, was dipped into the 
undiluted plasma at room temperature, withdrawn, and the adhering traces of plasma 
(not  a  loopful)  was  stirred  into  Staphylococcal  suspension  on  the  slide.  The 
procedure was repeated for the control suspensions. 
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4. The test was read as positive if visible coarse clumping occurs within       10 
seconds, and read as negative if clumping was absent or if any of the reactions took 
more than  10 seconds  to  develop.  However,  any  slow reacting  strains  were  re-
examined by the tube test. 
b. Tube Coagulase test   82, 84   (modified from Gillespie 1943)
This test detects both bound and free coagulase.
1. A 1 in 6 dilution of plasma in saline (0.85% Nacl) was prepared, and subsequently 
1ml volumes of the diluted plasma were aliquoted into small tubes.
2. A staphylococcal colony being tested was emulsified in a tube of diluted plasma.
3.  For  each  batch  of  tests,  known  Coagulase-negative  and  coagulase-positive 
cultures were included as controls. In addition, a tube of unseeded diluted plasma 
was included to confirm that it does not coagulate spontaneously.
4. The tubes were incubated at 370C for up to 4 hrs.
5. The test samples were examined at 1, 2 and 4 hour intervals for clot formation, by 
tilting the tube through 900.
6. Negative tubes were left at room temperature overnight and re-examined the next 
day.
7. The test was read as positive if any degree of clot formed, and read as negative if 
the plasma remained wholly liquid showing only a flocculent or ropy precipitate.
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Speciation                         
                     
The collected  CoNS isolates  were  speciated  by  using  five  tests  simple  scheme 
method6 (appendix-  1).  The scheme combines one susceptibility  test  (novobiocin 
resistance test) with tests for urease, PYR, Ornithine decarboxylase,  and aerobic 
acid from mannose. These tests were performed according to the reference method. 
Only one or two additional tests were used to resolve each species group: trehalose 
and mannitol for the S. epidermidis group, acetoin production and lactose for the S. 
haemolyticus  group,  trehalose  for  the  S.  saprophyticus  group,  anaerobic 
thioglycolate growth for the S. warneri group, and xylose for the S. cohnii group.
1. PYR Test 39
Principle
This test  is a useful  phenotypic  test  for  speciation  of  CoNS. The L-Pyrrlidonyl-ß-
naphthylamide is cleaved by the aryl amidase, which is produced by the organism, to 
L-pyrolidone and free β-naphthylamide. These, then combine with the PYR reagent 
(p-dimethyl amino cinnamaldehyde) to produce red colour.
PYR Agar (Himedia)                                                          
Beef  heart,  infusion  500  gms/litre  from  20  gms/litre  of  Peptic  digest  of  animal 
tissue, Dextrose 2.0 grams/litre, Sodium chloride 2.0 grams/litre,               Disodium 
phosphate 0.40 grams/litre, Sodium carbonate 2.5 grams/litre, Chromogenic mixture 
0.10 grams/litre, Agar 5.0 grams/litre.             
45
PYR Reagent
N, N–Dimethyl  amino cinnamaldehyde 1.0 gram, Hydrochloric  acid (concentrated) 
1.0 ml, Distilled water 99.0 ml.
Method
The test isolate was inoculated on the PYR agar plate and incubated for      24 hrs.  
Chromogenic  mixture  in  the  agar  provides  substrate  for  PYR  enzyme.  After 
incubation,  1  drop of  PYR reagent  (R043)  was  added directly  to  any  suspected 
surface  growth  on  plate,  and  subsequently  observed  for  colour  change  after  2 
minutes.
Interpretation 
The appearance of red colour within 2 minutes was considered as positive reaction, 
while orange or pink colour appearance was considered as negative reaction.
2. Ornithine Decarboxylase test (ODC) 82 (Kloos & Lamble 1991)
The production of Ornithine Decarboxylase identifies S. lugdunensis. 
Medium
Peptone  5.0  grams,  Yeast  extract  3.0  grams,  L-Ornithine  hydrochloride  0.5%, 
Glucose 1grams, and Bromocresol purple 0.2%, in 1 litre of water.
Method
The test isolate was stab-inoculated into the medium, overlaid with a layer of sterile 
liquid  paraffin,  and incubated at  370C for  24 hrs.  The production  of  the enzyme 
decarboxylase by the organism in the tube was tested. 
46
Interpretation
The production of violet colour was read as production of the Decarboxylase, while a 
yellow colour was read as a negative reaction
3. Voges – Proskauer Test: 84, 85, 87 
Principle
The test  is performed to determine the ability  of  the micro organisms to ferment 
glucose with the production of acetyl  methyl  carbinol (acetoin).  This test helps to 
speciate CoNS.
Medium 
Glucose phosphate peptone water.
Method
 Five ml of the media was inoculated with the test isolate and incubated at 370C for 
48 hrs. Subsequently, 1 ml of 40% potassium hydroxide and 3 ml of 5% solution of 
α-naphthol in absolute alcohol were added and the contents were shaken vigorously 
for 30 seconds.  
Interpretation
Reddening of the supernatant within 5-10 mins due to acetoin production was read 
as positive reaction. A negative reaction was indicated by the development of yellow 
colour. 
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4. Carbohydrate utilization test 82,84
Principle                                                                                                         The test 
is used to determine the ability of an organism to ferment a specific carbohydrate 
which is incorporated in a basal medium, and to produce acid or acid with visible 
gas. Sugars tested included Mannitol, Trehalose, Lactose, and Xylose; these sugar 
tests help in further speciation of CoNS.
Medium
Sugar 1.0 gm, Nutrient broth base 100 ml, Bromothymol blue indicator1.2 ml. 
Method
The test media was inoculated with the cultural isolate and subsequently incubated 
at 370C for 24 hrs.
Interpretation  
A  positive  test  was  shown  by  yellow  colouration  of  the  medium  due  to  acid 
production;  no  colour  change,  due  to  inability  of  the  microorganisms to  ferment 
sugars, was read as negative reaction. 
5. Novobiocin sensitivity test 21 
This test differentiates S. saprophyticus from other CoNS.
Method
 A suspension of staphylococcal isolate, equivalent to 0.5 McFarland standards in 
turbidity was prepared and subsequently spread over MHA plate by using a sterile 
swab. A 5 µg Novobiocin disc was placed over the media by using heated forceps, 
and the plate was incubated for 24 hours.
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           Interpretation 
     
           The isolates were distinguished as saprophyticus if the inhibition zone was less than 
12 mm in diameter, and other CoNS if the inhibition zone was more than 12 mm in 
diameter
 6. Urease Test 82, 84
Principle  
The test  is  performed to determine the ability  of  microorganisms to  produce the 
enzyme urease. The occurrence of this enzyme can be tested for by growing the 
organism  in  the  presence  of  urea  and  subsequently  testing  for  alkali  (NH3) 
production by using a suitable pH indicator.
Medium 
Christensen’s urease medium: 
Peptone 1.0  gram,  Glucose (0.1%) 1.0  gram,  Sodium chloride  5.0 grams,  Mono 
potassium phosphate 2.0 grams, Phenol red 0.012 gram, Agar 15-20 grams, Distilled 
water 1000 ml.
Method
A drop of 4-6 hours old bacterial broth  culture was inoculated heavily over the entire 
slope surface. The sample, incubated at 370 C, was examined after 4 hrs or after 
overnight incubation. 
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Interpretation 
The test was read as positive reaction when the indicator turned purple–pink , and 
negative reaction when no change in colour occurred.
7. Growth in Thioglycolate broth
The  test  is  performed  to  determine  the  ability  of  microorganisms to  grow 
anaerobically.
Medium
Thioglycolate broth:  Casein 15.0 grams, Yeast extract 5.0 grams, Sodium chloride 
2.5 grams, Dextrose 5.5 grams, L-Cystine 0.5 gram, Sodium thioglycolate 0.5 gram, 
in 1000 ml of water.
Method
The test culture was inoculated in to the broth and incubated at 370C for 24hrs.
Interpretation 
The presence of turbidity indicates the growth of the organism.
BIOTYPING
Subgroups of S. epidermidis were distinguished by the biotyping scheme of Baird-
Parker11. The production of acid from lactose, maltose, and mannitol under aerobic 
conditions,  and  the  production  of  acetoin  as  described  earlier  in  carbohydrates 
utilization tests and Phosphatase test, were used to classify each culture into one of 
the four biotypes of Baird Parker.
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Phosphatase test 82, 84
Principle
The test  is  used to determine the ability  of  microorganisms to produce sufficient 
phosphatase enzyme for splitting phenolphthalein di phosphate.
Medium
Phenolphthalein phosphate Agar.
Method
The test and control cultures were spot-inoculated on to the plates, and the plates 
were incubated overnight at 37oC.  The plates with culture were inverted over the lid 
after adding few drops of ammonia solution in the lid.
Interpretation
The assay was  read as  positive  if  the  colonies  turned pink,  and negative  if  the 
colonies were colourless.
DEMONSTRATION OF VIRULENCE FACTORS 
The production of slime, lipase, lecithinase, DNAse, and hemolysin by the different 
isolates were determined.
Hemolysin production 4,87
Principle: To determine the production of hemolysin by CoNS.
Medium: Blood agar plates containing of 5% sheep blood.
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Method: The test culture isolates were inoculated on to Blood agar plates, and the 
plates were incubated at 37°C for 24 hrs. 
Interpretation:  A positive result was indicated by the formation of hemolytic zones 
around the isolated colonies.
Lipase production44
Principle: To determine the ability of CoNS isolates to produce the enzyme Lipase.
Medium: Sterile lipase reagent (HIMEDIA) was added (30% W/V) to spirit blue agar 
(HIMEDIA) which had been autoclaved at 1210C for 15 min. 
Method:The test culture isolates were spot-inoculated on to the spirit blue agar plate 
along  with  known  positive  and  negative  controls.  The  inoculated  plates  were 
incubated at 37°C for 48 hrs. 
Interpretation:Lipolytic strains gave a dark blue clear zone beneath and around the 
colonies. 
Lecithinase production 87,5,50
Principle:  To  determine  the  ability  of  CoNS  isolates  to  produce  the  enzyme 
lecithinase.  
Medium: BHI agar 100 ml; Yolk of 1 egg (Egg yolk is added to BHI agar which had 
been autoclaved at 1210C for 15 mins and cooled to 450C)
Method:  Test culture isolates were spot-inoculated on to the egg yolk agar plate, 
along with known positive and negative controls, and the contents were incubated at 
37°C for 48 hrs. 
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Interpretation:  Positive  reactions  showed  a  glistening  or  opaque  zone,  or  both, 
around the colonies.
DNAse production44,87
Principle: To determine the ability of CoNS isolate to produce the enzyme DNAse. 
Medium: (Himedia) DNAse test medium that had been autoclaved for          15 mins 
at 1210C. 
   Method:  The test culture isolates were spot-inoculated on to DNAse agar plate 
with known positive and negative controls, and incubated at 37°C for    48 hrs. Plates 
were flooded with1%Toluidine blue and allowed to stand for   15 mins. 
Interpretation
 Any degree of clearing of the opaque media was read as a positive reaction.
Slime production
Principle
To determine the ability of micro organism to form biofilm, and also to evaluate the 
reliability of these methods for determining the most suitable screening method.
Microtitre plate method (MTP) 5,36
 • Isolates from fresh agar plates were inoculated into trypticase soy broth   (TSB) 
with 1% glucose, and the contents incubated for 48 hrs at 370C.
• The broth culture was diluted 1 in 100 with fresh medium.                              •  
Individual wells of sterile, polystyrene, 96 well-flat bottom Microtitre plates were filled 
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with 0.2 ml aliquots of the diluted cultures; un-inoculated broth served as a control to 
check for sterility and non-specific binding of media. 
 • The tissue culture plates were incubated for 24 hours at 37°C.
• After incubation, contents of each well were removed by gently tapping the plates. 
• The wells were washed four times with 0.2 ml of phosphate buffer saline (PBS, pH 
7.2) to remove free-floating ‘plank tonic’ bacteria.
• Biofilms formed by adherent ‘sessile’ organisms in plate were fixed with sodium 
acetate (2%) and then stained with crystal violet (0.1% w/v). 
• Excess stain was rinsed off by thorough washing with deionized water, and the 
plates were kept for drying. 
•Optical  density (OD) of  stained adherent  bacteria  were determined with  a micro 
ELISA autoreader (model680, Biorad) at a wavelength of 570 nm (OD570nm). 
• These OD values were considered as an index of bacteria adhering to surface and 
forming biofilms. 
•  To compensate for  background absorbance,  OD readings from sterile  medium, 
fixative, and dye were averaged and subtracted from all test values. • The mean OD 
value obtained from media control well was deducted from all the test OD values88 
(appendix-2). S.epidermidis ATCC 31432 strain is used as control.
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Tube method (TM) (Christensen et al) 5, 36
  A  semi qualitative assessment of biofilm formation was determined as
 •  TSB supplemented  with  1% glucose  in  tubes  were  inoculated  with  loopful  of 
microorganism from overnight culture plates, and the contents were incubated for 24 
hours at 37°C.
• The tubes were decanted and washed with PBS (pH 7.3), and dried.
• Dried tubes were stained with crystal violet (0.1%).
• Excess stain was removed and the tubes were washed with deionized water. 
•Tubes were then dried in inverted position and observed for biofilm formation. 
Biofilm  formation was  considered  positive  when  a  visible  film lined  the wall  and 
bottom of the tube. Ring formation at the liquid interface was not indicative of biofilm 
formation. Tubes were examined and the amount of biofilm formation was scored as 
absent/weak, moderate, or strong.
Congo red Agar method (CRA) 5, 39
An  alternative  method  for  screening  biofilm  formation,  as  described  by 
Freeman et al., for Staphylococcal isolates 
Medium  
BHI  (37.0  grams/L),  sucrose  (50.0  grams/L),  agar  (10.0  grams/L)  and 
Congo red stain (0.8 grams/L).
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Method
The test  culture isolates were inoculated on to CRA plates and incubated 
aerobically for 24 - 48 hours at 37°C.
Interpretation
The test  was read as positive  if  there were black  colonies  with  a  dry crystalline 
consistency. Weak slime producers were indicated by pink colonies with occasional 
darkening at the centers of colonies. A darkening of the colonies with the absence of 
a dry crystalline colonial morphology indicated an indeterminate result.
ANTIBIOTIC SENSITIVITY TESTING
Antimicrobial  susceptibility  testing  employs  the Kirby  Bauer  method  of  agar  disk 
diffusion performed with Mueller-Hinton agar plate. Commercially available antibiotic 
discs (Himedia) were used.  Various groups of 18 antibiotic discs (Appendix 3) were 
used to assess the antibiotic sensitivity pattern, MR and MDR among CoNS isolates. 
S.epidermidis ATCC 14990 strain is used.
Procedure
Using a sterile wire loop, 3-4 well-isolated colonies of similar appearance from an 
agar  plate  culture  were  inoculated  into  2-3  ml  of  suitable  broth  medium,  and 
subsequently emulsified. The turbidity was adjusted so as to correspond to the 0.5 
Mc farland standards. The test cultures were swabbed on the Muller Hinton agar 
plates and dried for not more than 15 mins. The discs were applied on to the surface 
of the agar; three plates were used for one isolate due to the increased number of 
discs. 
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Interpretation
Results  were  read  after  incubation  at  370C for  18-24  hrs.  The sizes  of  zone  of 
inhibition were interpretated by referring to the CLSI standards. 
(Detailed  procedure  about  inoculum preparation,  turbidity  standard  for  inoculums 
preparation, inoculation of test plates and interpretation of zone sizes  are  explained 
in Appendix 4)
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 RESULTS
                The present study was conducted on 90 clinically-significant CoNS 
isolates. All strains were negative for both clumping factor and tube coagulase.
   The most  common source for  all  CoNS species  combined was wound 
infections and pus, constituting 39 out of 90 strains (43%), followed by 21 (23%) from 
blood cultures, 14 (15.5%) from urine samples, 6 (6.6%) from catheters, 2 (3.9%) 
from cerebrospinal fluid, 4 (1.9%) from ascitic fluid, and   5 from other sources (Table 
& Chart 1).
Speciation was done by five-test simple scheme method which is based on 
the biochemical reactions, and the results are shown in              Table & Chart 2. All 
species groups were resolved to the species and        sub-species level by using 
additional tests. All 54  trehalose- and mannitol-negative isolates from S. epidermidis 
group were identified as S. epidermidis. From the S. haemolyticus group, 11 isolates 
produced acetoin, and hence were identified as pure S. haemolyticus. All 12 isolates 
in the                         S. saprophyticus group were trehalose-positive, and hence 
were determined to be subsp.saprophyticus. Out of the 7 S.warneri group isolates, 3 
were identified as S. warneri sp (anaerobic thioglycolate growth-positive), and 4 as 
S.  hominis  subsp.  hominis  (anaerobic  thioglycolate  growth-negative).  Of  the 
remaining 6 isolates, 4 were identified as S. lugdunesis sp, while 2 were determined 
to be S. capitis subsp. capitis.
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Table & Chart 3 lists the incidence of CoNS species among the clinical samples. Of 
the isolates from 40 exudate samples (wound swabs and pus),  24 isolates were 
identified as S. epidermis, 4 isolates were                   S. haemolyticus, 2 isolates  
were S. lugdunesis, 3 isolates were S. hominis,    2 isolates were S. warneri, and 2 
were S. capitis. Of the 21 blood samples,  14 harbored S.epidermidis, 4 harbored S. 
haemolyticus, and 1 each harbored either S. lugdunensis or S. hominis or S. capitis. 
Of  the isolates from           14 urine samples, majority (12) were S.saprophyticus,  
while only 2 were                      S. epidermidis. However, S. epidermidis was the 
most  common isolate  from wound & pus (26/39),  blood  (14/21),  catheters  (5/6), 
peritoneal fluid (2/3), CSF (2/2), and others (3/5); S. haemolyticus came second with 
1 isolate in each type of specimen.
Biotyping of the 54 S. epidermidis isolates by modified Baird-Parker system 
revealed that the majority, 32 (59%), of the isolates belonged to biotype II, while 14 
(25.9%) were of biotype I, 5 (9.2%) were of Biotype III, and 3 belonged to biotype IV 
(5.5%) (Table & Chart 4).
           The virulence factors of each species of CoNS isolates are listed in Table & 
Chart 5. Of the 54 clinically significant S. epidermidis isolates,          27 produced 
hemolysin, 6 produced lipase, 3 produced DNAse,  36 produced slime; none of the 
strains  produced  lecithinase.  Among  11  S.  haemolyticus  isolates,  8  produced 
haemolysin, 4 produced lipase, 1 produced DNAse, and 3 produced slime; however, 
none of the isolates produced lecithinase.
Among the 12 S. saprophyticus isolates, 2 produced haemolysin, 3 produced lipase, 
1 produced DNAse, and 6 produced slime; however, none of the isolates produced 
lecithinase. Of the 4 S. lugdunensis isolates, 2 produced either hemoysin or lipase, 2 
produced slime, and none of the isolates produced DNAse and lecithinase. Of the 3 
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S.warneri isolates, whi  2 produced haemolysin, none of the isolates produced slime 
or  lipase  or  DNAse  or  lecithinase.  No  virulence  factors  could  be  demonstrated 
among the                4  S.hominis and 2 S.capitis isolates.
             Table  &  Chart  7  lists,  maximum  slime  positivity  by 
S.epidermidis  (36  =10  heavy  +  26moderate),  followed  by  S.haemolyticus 
(6 = 2 heavy + 4 moderate),  S. saprophyticus (3 = 1 heavy + 2 moderate),  and 
S.lugdunensis (2 moderate). 
             Table & Chart 8 shows the relationship between the biotypes and slime 
production. A majority, 26 out of 36 (76%), of biotype II isolates produced slime, and 
9  out  10  (90%)  among  them  were  heavy  slime  producers.  Among  the  biofilm-
producing S. epidermidis isolates, 7 biotype I isolates (50%), 2 biotype III isolates 
(40%), and 1 biotype IV (30%) isolate produced slime.
             Of the 90 isolates tested by MTP method for biofilm formation,         13 (14%) 
were strong biofilm producers,  and 34 (37.7%) were moderate biofilm producers. 
Results  from the TM showed good correlation with  those obtained with  the MTP 
method – a total of 12 (11.8%) isolates were picked up as strong biofilm producers, 
while 29 (32%) were moderate biofilm producers. In contrast,  results obtained by 
using the CRA method presented a different picture. Majority of the strains produced 
red (pink  to  orange)  colonies  on medium,  which  is  a  typical  attribute  of  biofilm-
producing staphylococcal  isolates.  Though 1 (1.97%) isolate produced occasional 
blackening of  colonies, it did not display the dry crystalline morphology. After 24-48 
hours only 2 (2.2%) isolates produced red colonies with dry crystalline morphology. 
With  regards  to  the  colony  morphology  on  CRA,  no  correlation  was  observed 
between the results from CRA and MT P assays.
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         As evident from Table & Chart 10, antimicrobial susceptibility testing revealed 
wide-spread (54%) methicillin resistance among the CoNS isolates. MDR was also 
prevalent among the CoNS isolates, with a higher incidence among the methicillin-
resistant  isolates  than  the  methicillin-sensitive  isolates.  Though  resistance  to 
methicillin was highest (64%) among the                       S. haemolyticus isolates, the  
MR isolates exhibited only 36% of MDR and       57% of MDR among MR.
         Among the 63% methicillin-resistant S. epidermidis isolates,             88% 
exhibited MDR; however, overall MDR among S.epidermidis was 55%. Fifty percent 
and  42%  of  S.  lugdunensis  and  S.saprophyticus  exhibited  methicilin  resistance, 
respectively;  both exhibited 25% MDR. Among the    MR-isolates, 50% of MDR-
S.lugduensis  and  60% of  MDR-S.saprophyticus  were  methicillin-resistant.  Of  the 
33% MR- S. Warneri isolates, all were MDR. None of the S. hominis and S. capitis  
isolates exhibited MR and MDR. 
                   Analysis of the antibiotic susceptibility pattern of S. epidermidis and other 
CoNS isolates,  shown in  Table  & Chart  11,  revealed  no resistance to  Linezolid. 
Ninety eight  percent of S. epidermidis and 94% of the other CoNS isolates were 
Vancomycin-sensitive.   Maximum  resistance  was  observed  for  Amoxicillin  (S. 
epidermidis 81.5%, other CoNS 56%), followed by Cloxacillin (S. epdiermidis 74%, 
other CoNS 33%), Resistance to antibiotics was more among S. epidermidis isolates 
than other CoNS isolates. More than 80% of other CoNS isolates were sensitive to 
Amikacin, Ofloxacin, Levofloxacin, Azithromycin, and Clindamycin. 
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Table –1  Distribution of CoNS among the clinical specimens
No. Specimen       No. of CoNS    Percentage
1 Wound & Pus              39        43%
2 Blood               21        23%
3 Urine               14        15.5%
4 Catheters                 6         6.6%
5 Peritoneal fluid                 3         3.3%
6 CSF                 2         2.2%
7 Others                 5         5.5%
Total                 90              -
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Table – 2. Species distribution among CoNS isolates 
No.        Species No. of isolates Percentage
1 S.epidermidis            54       60
2 S.haemolyticus            11       12.2
3 S.saprophyticus            12       13.3
4 S.lugdunensis             4       4.4
5 S.hominis             4       4.4
6 S.warneri             3       3.3
7 S.capitis              2       2.2
Total           90        -
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Table-3.
  Frequency of species of CoNS isolates from clinical specimens
     
Species
W
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%
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S.epidermidis
                   54 26  (48) 14 (26) 2  (3.7) 5  (9.2) 2  (3.7) 2  (3.7) 3  (6.5)
S.haemolyticus
                  11 4   (36) 4   (36) 1   (9) 1  (9) 1   (9)
S.saprophyticus
                  12
 
12(100)
S.lugdunensis
                   4 2   (50) 1  (25) 1  (25)
S.hominis  
                   4 3   (75) 1  (25)
S.warneri   
                   3 2   (67) 1(33.3)
S.capitis    
                   2 2  (100)
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 Table-4.   Biotypes of S.epidermidis - Baird-Parker system
Specimen Biotype 1
    
Biotype2 Biotype3 Biotype4
Wound & Pus
                       26 
7 16 2 1
Blood
                       14
4 7 2 1
Urine
                        2
- 2 - -
Catheters
                        5
2 3 - -
Peritoneal fluid
                         2
- 2 - -
CSF 
                         2          
1 1 - -
Others
                         3
- 1 1 1
Total               54
14 32 5 3
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Table-5.  Frequency of virulence factors among CoNS isolates 
                   
     
Species Hemolysin
  n       %
Lipase
  n       %
DNAse
   n         %
Lecithinase Slime
  n       %
S.epidermidis
                     
  27    (50)   6    (11)    3     (5.5)          0  36   (67)
S.haemolyticus    8     (72)   4    (36)    1     (9)         0   3    (27)
S.saprophyticus    2     (17)   3    (25)     0         0    6   (50)
S.lugdunensis    1     ( 25)   1    (25)     0         0    2   (50)
S.hominis    0     ( 0)   0     0         0    0
S.warneri    2     (67)   0     0         0    0
S.capitis    0     ( 0)   0     0         0     0
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Table-6.    Production of Slime with regards to specimen
No. Specimen
Heavy slime 
Producer
Mod. slime 
Producer
      
       Total   
      n       %
1 Wound & Pus
                     39
    
          6
    
      16
      
      22   (56.4)
2 Blood
                     21
      
          2
      
       6
       
       8     (38)
3 Urine
                    14
      
          1
      
       2
        
       3    (21.4)
4 Catheters
                     6
      
         2
       
      4
       
       6    (100)
5 Peritoneal fluid
                     3
      
         1
      
      2
       
       3    (100)
6 CSF
                     2
      
          -
      
      2
       
       2    (100)
7 Others         
                    5 
      
         1
      
      2
       
       3     (60)
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 Table -7
 Distribution of Slime production among species of CoNS isolates
     
Species
Heavy slime 
Producer
    n              %
Mod. Slime 
Producer
 n          %
Total
     n           %
S.epidermidis
                        54
   
   10           (18.5)  26      (48.2)
     
     36       (66.8)
S.haemolyticus
                        11
   
     2            (18)    4      (36.2)
      
       6       (54.2)
S.saprophyticus
                        12
   
     1            (8.3)    2      (16.6)
       
       3       (24.9)
S.lugdunensis
                        4
   
             --    2      (50)
      
        2       (50)
Total
                      
    
13      34        47      
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 Table-8 
 Slime producing S.epidermidis isolates according to biotypes
Biotypes     No. of slime producers 
       TotalHeavy Moderate
Biotype I  (14)       1       6           7(50%)
 Biotype II  (32)       9       17           26 (81%)
 Biotype III  (5)       0         2           2  (40%)
 Biotype IV  (3)       0         1           1(33%)
Total  (54)      10        26           36(66%)
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 Table-9
Comparison  of  biofilm  formation by MTP, TM and CRA method
Biofilm formation        MTP        TM     CRA
High   (13)         13         12     0
Moderate(34)         34         29      3 
Non  biofilm 
producers(43)
        
         43
        
         49
    
    87 
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Table-10. Frequency of MR CoNS and MDR CoNS
Sl. 
No 
            Species  No. of MR
  Isolates :
  
 n        % 
 No. of MDR Isolates: %
MDR among 
CoNSspecies
MDR among
MR isolates
1 S.epidermidis      (54)  34    ( 63)   30 /54   (55%)  30/34   ( 88%)
2 S.haemolyticus   (11)   7      (64)    4/11     (36%)   4 /7      (57%)
3 S.saprophyticus  (12)   5     (42)    3/12     (25%)   3/5      ( 60%)
4 S.lugdunensis       (4)   2     (50)    1 /4      (25%)    1 /2     (50%)
5 S.hominis             (4)   0      (0)    0/4       ( 0%)    0         (0%)
6 S.warneri              (3)   1     (33)    1/3       (33%)    1/1     (100%)
7 S.capitis               (2)   0      (0)    0 /2       (0%)    0         (0%)
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Table -11.   Antibiotic sensitivity pattern of
S.epidermidis and other CoNS isolates.
  
   Antibiotics 
       No. of susceptible isolates
S.epidermidis
     (54)      %
 Other CoNS
  (36)         %
1. Oxacillin       20      ( 37)    21      ( 58)
2 Amoxicillin       10      (18.5)    16       (44)
3 Cloxacillin        14      (26)    24       (67)
4 Piperacillin        38      (70)    28       (78)
5 Amikacin         42     ( 78)    32       (89)
6 Gentamicin         14     ( 26)    20       (56)
7 Ciprofloxacin          34     (63 )    27       (75)
8 Ofloxacin           40    (74)    29       (80.5)
9 Levofloxacin           43    (80)    32       (89)
10 Erythromycin           24    (44)    28       (78)
11 .Azithromycin           30     (56)    29       (80.5)
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12 Clindamycin            33    (61)    29       (80.5)
13 Vancomycin            53    (98)    34       (94)
14 Linezolid            54    (100)    36       (100)
15 Cephalexin            18     (33)    21       (58)
16 Cefoxitin            22     (41)     20       (56)
17 Cephotaxime            15     (28)     23       (64)
18 Cefepime            38     (70)    26         (72)
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 DISCUSSION
Historically,  due  to  their  ubiquitous  nature,  the  coagulase-negative 
staphylococci  have been regarded as saprophytes with little pathogenic potential. 
However,  recently,  CoNS  have  emerged  as  significant  pathogens,  particularly  in 
infections associated with  medical  devices  and in  immuno-compromised patients. 
CoNS are among the most frequently isolated bacteria in the clinical microbiology 
laboratory.
In the present study, 135 CoNS were isolated from different clinical 
specimens from different sources; Ninety (66%)  among them fulfilled the criteria, 
and hence were considered as clinically-significant and included in this study. This 
level  of  clinical  significance  (66%)  is  comparable  to that  reported by  Ishak et  al 
(1985)  52(52%), Maria de Lourdes Ribeiro de Souza da Cunha et al (2006)4 (51%) 
,and by Mohan et al (2002)35 (44.3%).  In contrast, Sewell et al(1982) 9 reported  that 
only 21% of CoNS isolates were clinically significant; this discrepancy might have 
arisen due to their inclusion criteria that considered organisms from closed sources 
such as blood, sub-arachnoid space, joint, or pleural space to be more pathogenic 
than the organisms which were isolated from an open source such as a wound. 
Accordingly, if  the inclusion criteria used by Sewell et al is employed in the current 
study, only 26.9% of CoNS will account as  clinically significant.
In the present  study, majority (43%) of the isolates were from wound 
infections  &  pus,  while  23%  were  from  blood  cultures,  15.5%  were  from  urine 
samples, 6.6% were from  IV catheters, 3.9% were from cerebrospinal fluid, 1.9% 
were  from ascitic fluid,  and 2% were from other sources. Intriguingly,  the above 
data correlates with the results published  by Sewell et al  9, who reported drainage 
from wounds as the most frequent source of CoNS(43%), followed by blood (26%), 
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urine(12%), peritoneal           fluid (9%),  cerebrospinal fluid (8%), joint fluids (1%),  
and pleural fluid (1%).  In addition, results from this study also correlate well with the 
study by    Goyal et al 2 (2006) which  identified wounds as the most frequent source 
of  CoNS (38.2%)   followed  by  urine  samples  (28.4%),  blood  cultures  (14.7%), 
catheters (10.7%), cerebrospinal fluid (3.9%), each from synovial fluid (1.9%), and 
ascitic fluid (1.9%).
          Contrasting results were published by Vee j Gill  et al (1983)31 who 
reported that blood was the most common source for CoNS isolates (50%), followed 
by wounds and abscesses (17%), and I.V. catheter tips(11%). However, the above 
study  included  only  the  organisms  from  wounds  and  abscesses  that  displayed 
moderate to heavy growth. Two additional reports further highlight the prevalence of 
variability in these type of studies -      Mohan et al 35 (2002) determined urine as the 
most common source of CoNS (48.4%), followed by pus (18%), drain tips/ catheter 
tips/I.V.cannulas  (11.4%),  blood  (5%),  and  aural  swabs  (2.7%);  De  paulis  et 
al(2003)6  also  identified  urine  as  the  most  common  source  of  CoNS  (35.8%), 
followed by pus (15%), blood (13%), central venous catheters (11%), aural swabs 
(2.7%), peritoneal dialysis fluids (9.5%), and cerebrospinal fluids (1%).
The differences observed in the distribution of CoNS among clinical 
specimens  between  different  studies  may  have  resulted  from  the  use  of  non-
standard criteria for defining the clinical  significance and for selection of clinically 
significant CoNS isolates. 
Several methods exist for determining CoNS species. For example, 
the  method  of  Kloos  and  Schleifer  is  a  reliable  technique  for  identification  and 
speciation of CoNS. However,  it  is a relatively cumbersome, and time consuming 
method requiring the use of expensive reagents. Alternative approaches include the 
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use  of  the  several  commercially-available  identification  kits  and  automated 
instruments;  however,  several  factors  precluded  their  use  in  this  study.  Hence, 
convenient, reliable, and inexpensive identification methods were opted. Among the 
different approaches, the five-tests simple scheme by DePaulis et al (2003) 6, which 
identified 99.5% of CoNS isolates, was chosen. This level of accuracy is not possible 
with other approaches that were considered, including the nine tests scheme by Iorio 
et al(2007)14 (98.5% accuracy), and rapid 4 h method (UZA method) developed by 
Ieven et al(1995)30 (97.7% accuracy). In the case of the simple scheme, a two-step 
procedure, used by Goyal et al (2006) 2, it does not include the important   PYR test 
to differentiate the warneri species. 
                    In the present study, the most common species isolated from all the 
sources  were  S.  epidermidis  (60%),  followed  by  S.  saprophyticus  (13.6%),  S. 
haemolyticus (12%), S. hominis (4.4%), S. lugdunensis (4.4%), S. warneri (3.3%), 
and  S.  capitis  (2.2%).  This  distribution  pattern  correlates  well  with   the  results 
published by De Paulis et al(2003)6 which pegged the incidence of    S. epidermidis 
at 50.5%, S. haemolyticus at 18.5%, S. saprophyticus      subsp.saprophyticus at 
16.0%, S.lugdunensis  at 6.0%, andS.warneri at 2.5%  among the CoNS isolates. 
Another study conducted by Goyal et al (2006)2  reported similar incidence rates for 
S.epidermidis (41%), S.saprophyticus (16.6%), S. haemolyticus (14.7%), S. hominis 
(14.7%),  S.  lugdunensis(4.9%),  S.schleiferi  (1.9%),  and  S.capitis  (1.9%)  among 
isolates; S.warneri could not be differentiated in this scheme of speciation. Recently, 
Iorio et al (2007)32 also reported similar distribution of staphylococcal isolates from 
different  clinical  sites-  S.epidermidis(34.8%),Shaemolyticus(22.2%), 
S.hominis(12.6%)  S.saprophyticus  subsp.  saprophyticus  (4%),  S.  warneri  (3.5%) 
,S.lugdunensis  (3%),  S.  capitis  subsp.  capitis  (3%),  S.  cohnii  subsp.  urealyticum 
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(2%),         S.sciuri subsp. sciuri (2%), S.xylosus (2%),S.capitis subsp urealyticum 
(1%), and S. cohnii subsp. cohnii (1strain). 
      In the current study, majority of the isolates from the                          40 
exudate samples  ( wound swabs & pus ) were S. epidermidis (67%), 
followed  by    S.  haemolyticus  (10.2%), S.hominis  (7.6%),  S.lugdunensis  (5%), 
S.warneri (5%) and S.capitis (5%). Similar findings were reported by       Sewell et al 
(1982)9 and Kleeman et  a  l(1993)13.  In  contrast,  Shubhra  Singh(2008)64 reported 
28.57% of saprophyticus among wound isolates.
             In the present study, among 21 blood samples, 66% were S.epidermidis, 
19% were  S.haemolyticus,  and 4.7% each were   S.lugdunensis  or S.hominis  or 
S.capitis; this data correlates well with the  findings by Eng et al(1982) 15. Both Vee j. 
Gil et al(1983)31 and Maria de Lourdes Ribeiro de Souza da Cunha et al(2006)4 , 
reported S. epidermidis,  S.haemolyticus, and S. hominis as the first,  second, and 
third  most  frequently  encountered  species,  respectively,  followed  by  warneri.  In 
contrast,  Shubhra Singh(2008)64 reported  57.14 % of  saprophyticus  among  blood 
isolates, while De Paulis et al(2003)6 identified 1 S.saprophyticus out of 26 blood 
isolates(3.8%).
                      In this study, majority of the isolates from the 14 urine samples were S. 
saprophyticus (86%), followed by S.epidermidis (14%). Similar results were obtained 
in a study by Goyal et al(2006)2.  In contrast, Gill et al (1983) 31 reported that 63% of 
the  urinary  isolates  were  S.  epidermidis,  while  11%  were  S.  saprophyticus. 
Intriguingly,  Shubhra Singh (2008)  64reported an incidence of  15% S. epidermidis 
and 14% S. hominis among the urinary isolates, while S. saprophyticus could not be 
isolated.
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   In the current study, when  the 54 S. epidermidis  isolates  were biotyped 
by  modified  Baird-parker  system,  majority  of  the  isolates  belonged  to  biotype  ll 
(59%),  followed by biotype l  (25.9% ),  Biotype III  (9.2%),  and biotype lV (5.5%). 
Similarly, NiranjanNaik et al (2007)60 reported that     46.3%, 28%, 15% and 10.5% of 
the isolates belonged to Biotype ll,  I,  lll  and lV, respectively.  However, Bonnie M. 
Males et al (1975) 29 found Biotype l to be the predominant group in their studies; this 
difference  could be due to the fact that most of the isolates were from urine, and 
also because of the use of the tube phosphatase test instead of plate method. 
The  pathogenisity  of  CoNS  are  evaluated  by  demonstrating  the 
virulence factors 4,21 . Results from the present study are as shown in Table&chart 5 - 
haemolysins were produced by isolates of S.  epidermidis,     S.  haemolyticus,  S. 
saprophyicus  S. lugdunensis, and S. warneri, but not by strains of S. hominis and S. 
capitis. Similar results have been reported by Kloos and Schleifer 32(1975), Lambe et 
al94 (1990), and Cunha et al88 (2004). In the present study, 72% of S. haemolyticus 
and 54% of S. epidermidis were found to produce haemolysin; however, Pairisi et 
al29 (1975) reported that 79%  of  S. epidermidis produced  hemolysin. 
                       Lambe et al (1990)89 reported that most S.epidermidis             S. 
warneri, and S.hominis strains included in their study produced lipase and DNAse. 
However, the present study found most of the clinically significant     S. epidermidis, 
S. haemolyticus and S. lugdunensis strains to produce lipase. The findings from the 
current study find validation in a previous publication by Ribeiro de Souza da Cunha 
et al4 (2006), which reported very similar observations. In the case of DNAse, while 
the present study found only        S. epidermidis and S. haemolyticus to produce 
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DNAse, Ribeiro de Souza da Cunha et al4 (2006) et al found that, in addition to the 
two strains ,                  S. lugdunensis and  S. simulans also produced  DNAse.
                         The production of Lecithinase by 1 S.epidermidis and                1 S. 
warneri, was reported by Ribeiro de Souza da Cunha et al4. But in the present study, 
none of the strains were found to produce lecithinase. 
                   The most important  colonizing and  virulence factor,  i.e.  biofilm 
production, in CoNS was evaluated. Forty seven out of 90 (52%) isolates produced 
slime in this study. Comparable results have been previously published by Deighton 
et al (1988)47, Kotilainen et al (1990).49, and        Mathur et al (2006) 5 who found that 
48%, 65%, and 53.9%, respectively, of the CoNS in their studies produced biofilm. In 
contrast,  Ishak  et  al  (1985)  52 found  92.8%  of  clinically-significant  bloodstream 
isolates  of  CoNS producing  slime;  however,  it  should  be noted here  that  all  the 
isolates used by         Ishak et al were from blood. Among the species included in the 
present study, S. epidermidis and S. haemolyticus were the only two species that 
produced almost all the virulence factors.
                       When specimen-related slime production was assessed   (Table&  
chart  6),  100%  slime  production  was  seen  among  isolates  from  IV  Catheters, 
Peritoneal fluid, and CSF, followed by, 56.4% from wound & pus, 38%  from blood , 
21.4% in Urinary isolates and 60%s from other sources .    It is interesting to point 
out  here the findings by  Makhija  S.K.  et  al  (1995)57,  where  66% and 20% slime 
production was demonstrated in CSF and peritoneal fluid, respectively.
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In the present  study,  out  of  90 CoNS isolates  (Table&chart  7),  S. 
epidermidis  was  the  major  species  that  produced  slime  (67%),  followed  by 
S.haemolyticus (27%), S.saprophyticus (50%), and S.lugdunensis (50%). 
Comparable pattern of slime production by S.epidermidis species was observed by 
Rathinam. K. et al (1993)55  (62%), Kleeman et al (1993)8(64.5%), Agarwal et al  66 
1987 (48.7%), Deighton et al47 1988 (53%) and Ishak et al52 (1985 reported that 92% 
of S.epidermidis produced slime; however, only blood isolates were included in that 
study.
      Riley and Schneider (1992) suggested that slime production does not 
seem to be an important virulence factor of S. saprophyticus that were isolated from 
women  with  urinary  tract  infection42;  however,  in  the  present  study,  the  S. 
saprophyticus  isolated from urine samples  produced slime.  The reason might  be 
because, most samples were from patients with urinary catheters which functions as 
a foreign body assisting in the formation of slime as has been previously reported by 
Longaurova et al (2006) 42 .
      When  the  slime-producing  S. epidermidis  isolates  were  assessed 
according to biotypes (Table & Chart 8), 26 out of the 32 biotype II isolates exhibited 
slime productivity, followed by 7 out of the 14 biotype l isolates, 2 out of the 5 biotype 
lll isolates, and 1 out of the 3 biotype lV isolates produced slime. Such maximum 
slime production  by biotype  II  isolates  has previously  been reported by Niranjan 
nayak et al (2007)60 and Christesen et al(1983)8 . In contrast, Bonnie M. Males et al 
(1986)29 found maximum slime production among the Biotype l isolates; however, the 
caveat in that study was that the majority of the isolates used belonged to biotype l 29.
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    When the biofilm production was compared by 3 different methods, MTP 
method was the most sensitive as it could detect all the slime producers, whereas 
TM correlated well with the MTP method for strong biofilm producing strains; weak 
slime producers  were  difficult  to  discriminate  from biofilm-negative  isolates. CRA 
does not correlate well with either of the above two methods for detecting biofilm 
formation in staphylococci. The MTP method was found to be the most sensitive, 
accurate and reproducible  screening method for  detection of  biofilm formation by 
staphylococci. It also has the advantage of being a quantitative model to study the 
adherence of staphylococci on biomedical devices, a finding that correlates very well 
with the reports by Christensen et al(1983)8 and Mathur et al(2006)5.
     Antimicrobial  susceptibility  testing  revealed  wide  spread  methicillin 
resistance (54.4%) among the CoNS Isolates (Table & chart 10). Comparable levels 
have previously been reported by Chaudury et al (2007)65(68.4% oxacillin resistant 
CoNS) and Marry et  al  (1996).63 (49% methicillin  resistant  CoNS).  In a study by 
Shubhra Singh et al (2006)64, 38% of the CoNS exhibited oxacillin resistance.
                 In the present study,  S. haemolyticus showed highest methicillin  
resistance (64%), followed by S.epidermidis (63%); these values are similar to those 
reported by Vee J. Gill et al (1983)31.
              The antibiotic susceptibility pattern of S. epidermidis and other CoNS 
isolates, shown in Table &chart 11, revealed no resistance to Linezolid. Ninety eight 
percentage of S.epidermidis and 94% of the other CoNS isolates were sensitive to 
Vancomycin. More than 70% of S.epidermidis isolates were sensitive to Piperacillin, 
Amikacin, Ofloxacin, Levofloxacin and Cefepime. More than 80% of the other CoNS 
isolates  were  sensitive  to  Amikacin,  Ofloxacin,  Levofloxacin  Azithromycin  and 
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Clindamycin. These findings correlate well with similar observations made by Archer 
et al(1994)70 and  Diekema et al  (2001)90
           MDR was also prevalent among the CoNS isolates; the prevalence was more 
in  the methicillin-resistant  isolates  than in  the methicillin-sensitive isolates.  These 
findings are very similar to those reported by                       Archer et al (1994) 70 and 
Diekema et al90  (2001).
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 SUMMARY
  A total of 135 CoNS were isolated from deep wounds, blood samples, pus, 
urine  samples,  body  fluids  and   IV  catheters  from   the  patients   at 
Diagnostic  microbiology  laboratory,  Dept  of  Microbiology,  Coimbatore 
Medical College, Coimbatore, during the period of    June, 2007 to July, 
2008.
 Nintey out  of 135 (66%) isolates which  fulfilled  the criteria were 
considered as clinically significant  and were included in the present study.
 Majority (43%) of the isolates were from wound and pus followed by blood 
(23%), urine (15.5%),  IVcatheters (6.6%), CSF (3.9%)     ascitic fluid 
(1.9%)  and from other sources (5.5%).
 When the 90 isolates were speciated by the five tests simple scheme 
method 60% were S.epidermidis, followed by S.saprophyticus 13.6%,  S. 
haemolyticus 12%,  S. hominis 4.4%,  S. lugdunensis 4.4%, 
S.warneri 3.3% and  S.capitis 2.2%.
 S.epidermidis was the most common species isolated from wound & pus, 
blood, IVcatheters, peritoneal fluid, CSF, and other sources.  
 S.saprophyticus (12) was solely isolated from urine which constituted 86% 
of urinary isolates..
 Among the 54 S.epidermidis isolates ,59%, 25.9%, 9.2% and 5.5% 
belonged to Baird-parker biotype - ll ,  l,  lll, and lV respectively.
  When the pathogenisity was evaluated by determination of the virulence 
factors , haemolysin, lipase and slime were produced by      S. epidermidis, 
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S.  haemolyticus  ,  S.saprophyticus  and  S.lugdunensis.   S.  warneri 
produced only haemolysin.
 DNAse was produced by only 3 of the 54 S. epidermidis isolates and     1 of 
11 S. haemolyticus isolates.
 Lecithinase was produced by none of the isolates.
 All  (100%)   isolates  from  IVCatheters,  Peritoneal  fluid  ,CSF   exhibited 
slime, while 56.4% isolates from wound & pus , 38% isolates from blood , 
21.4% isolates from urine and 60% isolates from other sources produced 
slime.
 S.epidermidis was the predominant slime producing species (75%) followed 
by S. haemolyticus  (13%), S. saprophyticus  (6%)  and              S. 
lugdunensis ( 4%).
 Among the biotypes of  S.epidermidis isolates, maximum number of biotype 
ll isolates  produced slime (72%) followed by biotype l
             isolates (50%), biotype lll isolates(40%) and biotype lV isolates (30%) 
• Among  the 3 different methods  used for  detecting the biofilm production , 
MTP method Identified all slime producers  and  was sensitive enough  to 
differentiate strong, moderate & non slime producers.
 TM method identified 87% of slime producers and it correlated well with the 
MTP method for strong biofilm producers, where as weak slime producers 
were difficult to discriminate from non biofilm producers. 
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  By  CRA  method  only  3  isolates  were  identified  as  moderate  slime 
producers.  No correlation  was  observed between colony morphology on 
CRA and MTP results.
 Methicillin resistance was 54.4% among the CoNS Isolates.
 Highest  methicillin  resistance  was  exhibited  by  S.  haemolyticus  (64%) 
followed by S.epidermidis (63%).
 MDR was also prevalent  among CoNS isolates and the prevalence was 
more in the methicillin-resistant isolates compared with methicillin sensitive 
isolates.
 MDR among  the CoNS isolates was 55% in S.epidermidis, 36% in       S. 
haemolyticus,  33%  in  S.  warneri,  25%  in  S.  saprophyticus  and 
S.lugdinensis.  
 The antibiotic susceptibility pattern revealed 100% sensitivity to Linezolid. 
Ninety-eight  percent of  S.epidermidis  and  94%  of  other  CoNS  isolates 
were sensitive to Vancomycin.
 Maximum resistance was observed for Amoxicillin (S. epidermidis 81.5% 
,other  CoNS  56%)  followed  by Cloxacillin  ,  Gentamicin,  Cephotaxime 
,Cephelexin,Oxacillin , Cefoxitin  and  Erythromycin.
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                                     CONCLUSIONS         
               The study of CoNS isolated from various sources indicated 66% of isolates 
as  clinically significant and S. epidermidis as the most frequently isolated species. 
The speciation  was done by five tests simple scheme method,  which is  reliable, 
simple, inexpensive, and accurate procedure and will  prove useful in microbiology 
laboratory as simplicity and speed are very essential in diagnostic and therapeutic 
purpose. The  most  important  virulent  factor  biofilm  production in  CoNS was 
associated mostly  in  prosthetic  device  related conditions  like  orthopedic  wounds, 
PDF, CSF and IV catheters and biofilm on implanted foreign material  can cause 
major medical and economic sequel. Antimicrobial susceptibility testing revealed the 
wide spread methicillin resistance and MDR among CoNS and is particularly notable 
with                  S. epidermidis. The prevalence of MDR was more in the methicillin-
resistant  isolates  and  in  slime  producers  as  cells  in  biofilms  are  normally  more 
resistant to antibiotics. It is necessary to predict the potential pathogenicity by biofilm 
demonstration  in  vitro  which  can  be  easily  done  by  MTP method  and antibiotic 
susceptibility of each clinical isolates, early in the course of infection, which will be 
helpful  to  provide  appropriate    antibiotic  therapy  and  prevent  implant  removal. 
Taking into consideration that the etiological  importance of CoNS has often been 
neglected, the present investigation confirmed that these microorganisms should not 
be ignored or classified as mere contaminants.
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                          Appendix-1: 
              Presumptive identification of CoNS by simple scheme
Species 
Novobiocin
(5µg)
 Urease Acid from-
mannose
PYR ODC
S. epidermidis group      S     + + - d
S. haemolyticus group       S - - + -
S. saprophyticus R + - - -
S. lugdunensis S D + + +
S. warneri group S + - - -
S. schleiferi subsp.schleiferi S - + + _
S. simulans S + d + -
S. capitis subsp. capitis S - + - -
S. cohnii subsp. cohnii R - D - -
S. cohnii group R + + d -
(+ Positive; - negative; d, positive or negative; R, resistant, S, susceptible) When 
Ornithine decarboxylase is negative:  
Trehalose negative; mannitol negative - S.epidermidis;
Trehalose positive; mannitol negative - S.caprae; 
 Trehalose negative; mannitol  positive - S. capitis subsp. ureolyticus 
Acetoin production positive - S. haemolyticus ; 
Acetoin production – negative; lactose negative - S. auricularis; 
Acetoin production negative ; lactose positive- S. casseolyticus   
Trehalose positive - S.saprophyticus subsp. saprophyticus; 
Trehalose negative, S.hominis subsp.novobiosepticus 
Anaerobic growth positive - S. warneri; 
Anaerobic growth negative- S. hominis subsp. hominis  
Xylose positive - S. xylosus; 
Xylose negative -S. cohnii subsp. urealyticum is suspected.
                                  
    Appenix-2 :  
Classification of bacterial adherence by MTP method 5,28
Mean OD values Adherence Biofilm formation 
<0.120
 0.120-0.240
 >0.240
 
Non
 Moderately
 Strong 
Non / weak
 Moderate
 High 
Chose the number 0.120 for a guideline because it  was three standard deviations 
(0.023)  above the mean OD (0.050) of a clean MTP plate stained by the previously 
described procedure 28.
                 
    
  Biotyping   of S.epidermidis isolates by Baird - Parker system
TESTS
BIOTYPES
1 2 3 4
ACETOIN
+ - + +
PHOSPHATASE
+ + - --
   
   
   
   
AC
ID
 
AE
R
O
BI
C
AL
LY
 F
R
O
M
LACTOSE + D - D
MALTOSE
+ - D D
MANNITOL
- - - +
(  + POSITIVE ,  -   NEGATIVE ,  D – VARIABLE )
Acetoin production  - Voges – Proskauer Test
Phosphatase -  Phosphatase test by plate method
Sugar fermentation tests  for Maltose, Mannitol, Lactose.
                                           
                                           
  
 Appendix - 3 . 
  
List of Antibiotic discs used and zone size interpretative chart. 
           
Antibioticdiscs Disc content
(mcg)
Resistant 
mm
Intermediate 
mm
Sensitive   mm
Oxacillin 1 17 - 18
Amoxicillin 10 19 - 20
Cloxacillin 5 17 - 18
Piperacillin 100 17 - 18
Amikacin 30 14 15-16 17
Gentamicin 10 12 13-14 15
Ciprofloxacin 5 15 16-20 21
Ofloxacin 5 12 13-15 16
Levofloxacin 5 15 16-18 19
Erythromycin 15 13 14-22 23
Azithromycin 15 13 14-17 18
Clindamycin 2 14 15-20 21
Vancomycin 30 - -- 15
 Linezolid 30 - - 21
Cephelexin 30 14 15-17 18
Cefoxitin 30 14 15-17 18
Cephotaxime 30 14 15-22 23
Cefepime 30 14 15-17 18
                     
Appendix-4
Antibiotic sensitivity testing by Kirby-Bauer disc diffusion  method. 
Inoculum preparation:          
               Using a sterile wire loop, touched 3-4 well isolated colonies of similar  
appearance from an agar plate culture and emulsified in a tube containing     2-3 ml of 
suitable broth medium.
               Adjusted the turbidity so as to correspond to the 0.5 Mcfarland standards. 
To perform this  step properly,  adequate light  is  needed to visually   compare the 
inoculums’  tube and the  0.5 Mc Farland standards against   a card with  a white 
background and contrasting black lines.
Turbidity standard for inoculums preparation:
•  To  standardize  the  inoculums  density  for  a  susceptibility  test,a  Barium  sulfate 
turbidity standard, equilent to a 0.5 McFarland standard was used.
• Preparation of Barium sulfate 0.5 Mc Farland standard:
• A 0.5 ml of aliquot of 0.048 mol/l (1.175% w/v Bacl2. 2H2O) is added to 99.5 ml of 
0.18 mol/L H2SO4 (1% v/v) with constant stirring to maintain a suspension.
• The correct density of the turbidity standard was verified and transferred the Barium 
sulfate suspension in 5-6 ml aliquot into screw cap tubes.
•These tubes were tightly sealed and stored in ambient temperature in the dark.
• The barium sulfate turbidity standard was  vigorously agitated  before each use and 
inspected for a uniform turbidity  appearance.
Inoculation of test plates:  After adjusting the turbidity of the inoculum’s suspension, 
a sterile cotton swab was dipped in to the suspension .Excess fluid  was removed by 
pressing  and rotating  the swab  against   the  side  of  the  tube  above the level  of 
suspension.
•  Streaked the swab evenly over the surface of  Muller  Hinton agar plate in  three 
directions, rotating the plate approximately 600 to ensure the even distribution.
• With the Petri dish in place allowed 3-5 minutes for the surface of agar to dry.
• Using sterile forceps the appropriate antimicrobial discs were evenly distributed over 
the inoculated plate. The disc should be about 15mm from the edge of the plate and 
no closer than about 25mm from disc to disc. Maximum of 6 discs can be placed in a 
90mm Petri dish plate. Each disc should be lightly pressed down to ensure its contact 
with agar. Three plates were used for one isolate due to the increased number of 
discs.
• The plates were incubated at 370C for18-24 hrs
Interpretation of zone sizes:
 After  overnight  incubation ,  examined the plates to ensure the confluent  or  near 
confluent  growth .Using a ruler held on the underside of the plate measured the 
diameter of each zone of inhibition in mm. The end point of inhibition is where growth 
starts.  The sizes  of  zone of  inhibition  were interpretated by referring to the CLSI 
standards, and the organisms are reported as susceptible, intermediate, or resistant 
to the agents that have been tested. In place of Methicillin, Oxacillin 1μgm discs were 
used.
                                             
 IV   PROFORMA
                
     
 NAME: 
                                                 
AGE/SEX:  
                        
ADDRESS:
OCCUPATION / INCOME:
IP/OP NO:                                                       LAB.NO:
                                               
WARD:  
                               
 SAMPLE:
Clinical significance:
 Fever  /     Purulent Discharge from wound /  
 prosthetic device / IV catheters/urinary catheters/peritoneal dialysis catheters
WBC                        /      ESR                           / CRP                 /  OTHERS
                                      
                                                 V PROTOCOL
  
            
MAC
           
BAP
WHITE OPAQUE
COLONIES
OTHERS
GRAMS
OFG , BACITRACIN
COAGULASE
 STAPH  MICRO
             GPC 
CATALASE
NEG-
STREP
POS - STAPH/MICRO
POS- STAPH AUR NEG- CoNS
SPECIATION BIOTYPING  AST VIRULENCE FACTORS
EXUDATES, BLOOD, URINE, IV
 CATHETER TIP, PDF, CSF, ETC.    
